bpc 157 maintenance dose BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Micro-Dosing: Is Less More
Description
For the longest usable life, store your pills the way the FDA advises for medicines in general closed, cool, and dry following the storage tips on where and how to store medicines, not in the bathroom drawer

But lets backtrack a moment to you
Orally bioavailable lead candidates will be tested in a comprehensive doseranging study to confirm efficacy on obesity and co-morbid endpoints

Explore supplements and tools recommended by Gary Brecka to help you optimize your health, based on your unique biology
